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ABSTRACT 
A number of sustained release formulations are available in the market which successfully sustained the drug release over a 
prolonged period of time by different mechanisms. The new approach for sustaining the drug release is disintegration control matrix 
tablet which sustained the drug release up to 24hrs by controlling the disintegration rate of tablet. Disintegration control matrix tablet 
(DCMT) mainly forms the granules containing drug and disintegrating agent such as low substituted hydroxyl propyl cellulose by 
various methods such as solid dispersion technique. The sustained release of drug is maintained by increasing the wax coating or 
decreasing the amount of disintegrants. The release of drug from tablet is uniform throughout till all the drug releases from tablet as 
it involves drug release by diffusion, dissolution and surface erosion mechanism. DCMT increases the solubility of drug and 
improves the bioavailability without disturbing gastrointestinal transit. BCS Class II, III, IV drugs are the best candidate for DCMT 
formulations. 
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INTRODUCTION 
Disintegration control matrix tablet (DCMT): 
DCMT is the novel approach employed for sustaining 
the drug release and increasing the solubility and 
bioavailability of drug. The drug release is controlled by 
the penetration of water in the matrix which is the rate 
determining step for dissolution of the DCMT. It 
contains water soluble matrix forming polymer, 
disintegrating agent, and wax which is insoluble or 
hardly soluble in aqueous body fluids and the release of 
drug is controlled by means of said resistance of coating 
layer or matrix against the diffusion of drug therein. In 
this preparation, the rate of the release decreases due to 
the decrease in the concentration gradient and the 
increase in the distance of diffusion, and therefore the 
amount of the release is approximately proportional to 
the square root of the time. 1, 2 
This system releases the drug from the matrix by 
different types of the mechanism such as follows 
These system release the drug from the matrix by 
different types of the mechanism such as follows 
1. Diffusion controlled: DCMT mainly contains 
disintegrating agent in various concentrations along 
with matrix forming polymer which are coated by 
wax and makes the drug release diffusion control, 
the coating material used is insoluble or hardly 
soluble in aqueous body fluids which resist the 
penetration of water in the tablet and due to the 
presence of water soluble polymer and disintegrants 
on the surface of tablet gets swells and diffuses the 
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granules from the swollen surface after they are 
being dissolved. 
2. Surface erosion phenomenon: This is the main 
mechanism by which the drug is released in DCMT, 
the presence of wax and water soluble polymer 
makes tablet to swells, due to swelling the water 
penetrates the swelling surface causes dissolution of 
drug and diffusion out of the swollen matrix. The 
drug release rate is highly dependent upon polymer 
swelling rate and the drug solubility. This system 
minimizes the risk of burst release of drug and 
prevents the dose dumping of drug. 
3. Dissolution controlled: The DCMT being the 
dissolution control however the dissolution is 
controlled to extend by the use of sustaining 
polymer such as HPMC. This polymer retard the 
drug dissolution in the formulation which delays its 
release time in the formulation, however the 
dissolution and the diffusion process occur 
simultaneously during the drug release in the 
DCMT.3 
     
Figure 1: Diffusion controlled drug delivery 
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Drug release in DCMT: 
DCMT follows the surface erosion phenomenon for drug 
release. The drug is distributed uniformly throughout the 
polymer matrix and the polymer phase in the erodible 
system decreases with time. However, in non-erodible 
system, the polymer phase remains unchanged with time 
and the drug is released by diffusion phenomenon. 
The drug release from surface erodible systems such as 
tablet, sphere, slabs and so on has been described in the 
form of mathematical equation proposed by Hoffenberg 
as follows: 
        (1) 
DCMT comprises of the granules containing drug and 
disintegrating agent which is formed by solid dispersion 
technique ,with the coating layer consisting of wax or 
hydrogenated soya bean oils, water soluble polymer and 
non-ionic surfactants(HLB <9) which is finally 
compressed into tablet to give sustain release 
formulation. The ratio of disintegrants: wax is very 
important to produce DCMT. The dissolution rate can be 
adjusted by using various grades of water soluble 
polymer in which increase in molecular weight increases 
the viscosity of the polymer which helps dissolution to 
became longer without altering other features. The main 
purpose of DCMT is to avoid drawbacks of diffusion 
control matrix tablet, reduce the dosing frequency, avoid 
the pH dependency for drug release, constant rate of 
drug release i.e. zero order release. 5 
Mechanism of drug release in DCMT: 
The drug release from DCMT starts with the penetration 
of water which leads to the swelling of the tablet surface 
due to the presence of insoluble polymer and soluble 
polymer. The swollen granules starts to separate from 
the tablet surface by diffusion and surface erosion 
phenomenon and finally the dissolution of drug from the 
separated granules the mechanism of drug release is 
described in the following figure 6 
 
 
Figure 2: Mechanism of drug release from DCMT
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Ideal drug candidate for DCMT:
 
The drugs that are poorly water soluble usually BCS 
class II and the drugs which readily recrystallize after 
the drug release, as happens in most of the cases of solid 
dispersion granules, are the ideal drug candidates for 
DCMT. In addition other class of drugs such as BCS 
class III&IV are also good drug candidate for the sustain 
release formulation as this sustains the drug successfully 
up to 24hrs.The drugs having the stability problem such 
as photo-stability are also considered ideal drug 
candidate for the disintegration control matrix tablet. 6 
Criteria for sustain release formulations: 
To develop a sustain release formulation, the drug must 
have half-life less than 7hrs and the dose of the drug 
should not be too large as it will create the problem in 
sustaining the drug release and also the dose dumping 
may occur due to large dose size. The drug must be 
stable in the intestine as sustain release formulation 
because it has to remain for longer duration of time and 
release the drug. The drug should have high therapeutic 
index and the molecular weight should be less than 1000 
Daltons. 7, 8 
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Principle of sustained release drug delivery system: 
In sustained release formulation the rate of drug release 
is very less than the rate of absorption and the rate of 
drug release from dosage form is the rate limiting step 
which make the sustain release formulation to follow 
zero order kinetics as shown in the following equation, 
Kr° = Rate In = Rate Out = Ke Cd Vd 
Where, Kr°: Zero-order rate constant for drug release-
Amount/time, Ke: First-order rate constant for overall 
drug elimination-time, Cd: Desired drug level in the 
body – Amount/volume, and Vd: Volume space in 
which the drug is distributed in liter. 9, 10 
Advantages of DCMT: 
The biggest advantage of DCMT is to increase the 
solubility of poorly water soluble drugs which is being 
completely dissolved and absorbed without disturbing 
the gastrointestinal transit. The drug releases at constant 
rate by zero order kinetics which is not dependent on the 
pH and maintains the constant release of drug up to 
24hrs without its recrystallization after release. The 
DCMT provides coating to the drug or granules which 
will not only mask the bitter or unacceptable taste or 
odour of drugs but also imparts stability to unstable 
drugs which might gets affected by the atmospheric 
condition such as light or moisture. 11 
Disadvantages of DCMT: 
DCMT involves three steps in the preparation which is 
thought to be time consuming, laborious and makes it 
expensive. The ratio of the wax and disintegrants should 
be in exact ratio and in proper proportion otherwise the 
formulation will not might follow the DCMT pattern for 
the release of drug. 
Formulation components of DCMT: 
Suitable drug: 
The drugs having poor water solubility usually BCS 
Class-II is usually considered best for the formulation of 
DCMT. Other class of drugs are also used only to 
develop a sustain release formulation. Drugs having 
stability problem (drugs having photo unstability) are 
also good candidates to develop DCMT. 
Disintegrating agent: 
The amount of disintegrating agent used in DCMT is 
about 10-60 % of the whole granule component; 
however the exact quantity can be determined during the 
optimization of its formulation. Various types of 
disintegrating agents are used in the formulation of  
DCMT such as; starch derivatives (corn starch, potato 
starch, rice starch, carboxy methyl starch), cellulose 
derivatives (sodium carboxy methyl cellulose, low 
substituted hydroxyl methyl cellulose(L-HPC), calcium 
carboxy methyl cellulose), gums ( gum Arabic), ion 
exchange resins (potassium polymethacrylate). 
Matrix forming agent: 
The amount of matrix forming agent used in DCMT is 
usually 5-30 weight percent of whole granule 
component. This gent plays a vital role in controlling the 
release of drug from the tablet. The matrix forming 
agent used may be synthetic of semi synthetic in nature 
which is selected depending on the type of release 
required in the formulation. The most common matrix 
forming agent used in DCMT is hydroxyl propyl methyl 
cellulose (HPMC) of various viscosity grades most 
commonly K-100M viscosity grade in sustained release 
formulations. 
Coating agent: 
Wax or hydrogenated oils are used as a coating agent for 
the coating of granules. The amount of wax or 
hydrogenated oils used in DCMT is preferably 30-65 % 
by weight of whole granule component. The wax or 
hydrogenated oils used for coating of granules should be 
hardly soluble or insoluble in water. The wax plays vital 
role in the penetration of water which in turn is used to 
control the disintegration rate and the drug release. 
Table 1: Examples of formulation component of 
DCMT 
2,6,12,13
 
Formulation 
Component 
Examples 
Drug Fabuxostat 
Eletriptan HBr 
Duloxetine HCl 
Fluvastatin 
Zidovudine 
Ziprasidone HCl 
Disintegrating 
agent 
Alginic acid 
Sodium alginate 
Crosspovidone 
Crosscarmillose 
Sodium starch glycolate 
L-hydroxypropyl cellulose(L-HPC) 
Corn starch 
Gum Arabic 
Potassium polymethacrylate 
Matrix 
forming agent 
(HPMC-K4M, HPMC-K-100M 
Sodium carboxy methyl cellulose 
Methyl cellulose 
Vinyl alcohol 
Ethylene oxide 
Hydroxyalkyl methacrylate 
Hydroxyl propyl cellulose 
Coating agent Carnauba wax 
Bees wax 
Hydrogenated soyabean oil 
Hydrogenated castor oil 
Paraffin wax 
Microcrystalline wax 
 
Dose calculations in sustain release formulation of 
DCMT: 
Dt= Dose (1+0.693*t/t1/2) 
Where, 
Dt= total dose of drug, 
Dose= dose of immediate release part, 
t= time during which sustained release is desired, 
t1/2= half life of drug. 
14 
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Preparation of disintegration control matrix tablet: 
Preparation of DCMT consists of three main processes 
such as preparation of solid dispersion granules, 
treatment or coating of granules with coating agent and 
finally compression of granules into tablet. 
Importance of solid dispersion: 
Solid dispersion (SD) is one of the processes used in the 
formulation of DCMT to prepare granules. SD is a 
widely accepted method to increase the solubility, 
dissolution and bioavailability of poorly water soluble 
drugs with increased absorption efficiency compared to 
parent drug. Improved solubility of drugs leads to 
decrease the dose and the dosing frequency of the 
formulation and ultimately the side effect, adverse 
effects and toxic effects. SD plays important role in the 
uniform distribution of a small amount of drug in solid 
state there by rendering the chances of dose dumping. 
The stability of the formulation is widely increased due 
to solid dispersion technique. 15 
Methods of preparation of solid dispersion: 
The solid dispersion is prepared by different methods 
which are mentioned below but till present literature the 
SD in disintegration control matrix tablet were prepared 
by two method i.e. solvent evaporation (vacuum drying) 
method and the kneading method. 
Melt or cool method: 
The melt or cool method includes two methods for the 
preparation of granules as melting solvent method and 
hot stage extrusion method. 
Solvent evaporation method: 
This is the another method used in the preparation of 
solid dispersion and include various methods for 
preparation of solid dispersion by this method such as 
vacuum drying, solvent evaporation, slow evaporation at 
low temperature, hot stage drying, spray drying, freeze 
drying. 
Co-precipitation method: 
This is the method of preparation of solid dispersion by 
precipitation from solution and includes method as 
Addition of an anti-solvent. 16, 17 
CONCLUSION 
Disintegration control matrix tablet is sustained release 
formulation that releases the drug in zero order kinetics 
with increase in solubility and bioavailability of poorly 
water soluble drugs. DCMT achieves the complete 
absorption of drugs without disturbing the 
gastrointestinal transit as in case of geriatrics patients. 
This is completely new approach for poorly water 
soluble drug as sustain release formulation which 
sustains the drug up to 24 hrs. 
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